Archive - June 2018
Daily Brief: BIO takes over from ASCO, Greece’s Novartis bribery case and more
ACT immunotherapy cures terminal breast cancer patient
AZ, MSD’s Lynparza/abiraterone combo hits prostate cancer goals
NICE rules against first-line use of Ipsen’s Cabometyx
Synergy Vision bolsters UK presence
EU filing for Clovis’ Rubraca in ovarian cancer maintenance setting
BMS’ Opdivo cuts risk of melanoma recurrence
US OKs first biosimilar of Amgen’s Neulasta
